Literature DB >> 21130494

Delineating domains and functions of NUP98 contributing to the leukemogenic activity of NUP98-HOX fusions.

Eric Yung1, Sanja Sekulovic, Bob Argiropoulos, Courteney K Lai, Malina Leung, Tobias Berg, Sarah Vollett, Vicky Chi-Dan Chang, Adrian Wan, Sandy Wong, R Keith Humphries.   

Abstract

To determine the contribution of the common N-terminal truncation of NUP98 in NUP98-translocations resulting in acute myeloid leukemia, we have conducted a structure-function analysis of NUP98 in the context of NUP98-HOXA10HD, a novel, canonical NUP98-Hox fusion that significantly enhances the self-renewal capacity of hematopoietic stem cells and collaborates with Meis1 to induce AML in our mouse models. Our results identify that NUP98 functions by transcriptional activation likely by recruitment of CBP/p300 via its FG/GLFG repeats. In contrast, the functional interaction of NUP98 with Rae1 or the anaphase promoting complex appears non-essential for its role in NUP98-leukemogenic fusions.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21130494      PMCID: PMC4072657          DOI: 10.1016/j.leukres.2010.10.006

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  24 in total

1.  Complex formation among the RNA export proteins Nup98, Rae1/Gle2, and TAP.

Authors:  Melanie B Blevins; Ashley M Smith; Erica M Phillips; Maureen A Powers
Journal:  J Biol Chem       Date:  2003-03-13       Impact factor: 5.157

2.  Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1.

Authors:  Nicolas Pineault; Carolina Abramovich; Hideaki Ohta; R Keith Humphries
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

Review 3.  Mitotic regulation of the anaphase-promoting complex.

Authors:  D J Baker; M M Dawlaty; P Galardy; J M van Deursen
Journal:  Cell Mol Life Sci       Date:  2007-03       Impact factor: 9.261

4.  Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculo-angiogenesis.

Authors:  Y Oike; N Takakura; A Hata; T Kaname; M Akizuki; Y Yamaguchi; H Yasue; K Araki; K Yamamura; T Suda
Journal:  Blood       Date:  1999-05-01       Impact factor: 22.113

5.  Chromatin-bound nuclear pore components regulate gene expression in higher eukaryotes.

Authors:  Maya Capelson; Yun Liang; Roberta Schulte; William Mair; Ulrich Wagner; Martin W Hetzer
Journal:  Cell       Date:  2010-02-05       Impact factor: 41.582

6.  Trans-repressive effect of NUP98-PMX1 on PMX1-regulated c-FOS gene through recruitment of histone deacetylase 1 by FG repeats.

Authors:  Xue-Tao Bai; Bai-Wei Gu; Tong Yin; Chao Niu; Xiao-Dong Xi; Ji Zhang; Zhu Chen; Sai-Juan Chen
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

7.  CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity.

Authors:  L H Kasper; P K Brindle; C A Schnabel; C E Pritchard; M L Cleary; J M van Deursen
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

8.  Selection of retrovirally transduced hematopoietic cells using CD24 as a marker of gene transfer.

Authors:  R Pawliuk; R Kay; P Lansdorp; R K Humphries
Journal:  Blood       Date:  1994-11-01       Impact factor: 22.113

9.  Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia.

Authors:  T Nakamura; D A Largaespada; M P Lee; L A Johnson; K Ohyashiki; K Toyama; S J Chen; C L Willman; I M Chen; A P Feinberg; N A Jenkins; N G Copeland; J D Shaughnessy
Journal:  Nat Genet       Date:  1996-02       Impact factor: 38.330

10.  The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9.

Authors:  J Borrow; A M Shearman; V P Stanton; R Becher; T Collins; A J Williams; I Dubé; F Katz; Y L Kwong; C Morris; K Ohyashiki; K Toyama; J Rowley; D E Housman
Journal:  Nat Genet       Date:  1996-02       Impact factor: 38.330

View more
  8 in total

1.  BMI1 suffers a degrading experience.

Authors:  Mark Hoenerhoff; Isabel M Chu; Jeffrey E Green
Journal:  Cell Cycle       Date:  2011-06-15       Impact factor: 4.534

Review 2.  NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights.

Authors:  Sheryl M Gough; Christopher I Slape; Peter D Aplan
Journal:  Blood       Date:  2011-09-26       Impact factor: 22.113

3.  Formation of Nup98-containing nuclear bodies in HeLa sublines is linked to genomic rearrangements affecting chromosome 11.

Authors:  Serge Romana; Isabelle Radford-Weiss; Jean-Michel Lapierre; Valérie Doye; Marie-Claude Geoffroy
Journal:  Chromosoma       Date:  2015-12-21       Impact factor: 4.316

Review 4.  Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies.

Authors:  Nicole L Michmerhuizen; Jeffery M Klco; Charles G Mullighan
Journal:  Blood       Date:  2020-11-12       Impact factor: 22.113

5.  Biomolecular condensation of NUP98 fusion proteins drives leukemogenic gene expression.

Authors:  Stefan Terlecki-Zaniewicz; Theresa Humer; Thomas Eder; Johannes Schmoellerl; Elizabeth Heyes; Gabriele Manhart; Natalie Kuchynka; Katja Parapatics; Fabio G Liberante; André C Müller; Eleni M Tomazou; Florian Grebien
Journal:  Nat Struct Mol Biol       Date:  2021-01-21       Impact factor: 15.369

6.  Phase separation drives aberrant chromatin looping and cancer development.

Authors:  Jeong Hyun Ahn; Eric S Davis; Timothy A Daugird; Shuai Zhao; Ivana Yoseli Quiroga; Hidetaka Uryu; Jie Li; Aaron J Storey; Yi-Hsuan Tsai; Daniel P Keeley; Samuel G Mackintosh; Ricky D Edmondson; Stephanie D Byrum; Ling Cai; Alan J Tackett; Deyou Zheng; Wesley R Legant; Douglas H Phanstiel; Gang Greg Wang
Journal:  Nature       Date:  2021-06-23       Impact factor: 69.504

7.  Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma.

Authors:  Andrew R Conery; Richard C Centore; Adrianne Neiss; Patricia J Keller; Shivangi Joshi; Kerry L Spillane; Peter Sandy; Charlie Hatton; Eneida Pardo; Laura Zawadzke; Archana Bommi-Reddy; Karen E Gascoigne; Barbara M Bryant; Jennifer A Mertz; Robert J Sims
Journal:  Elife       Date:  2016-01-05       Impact factor: 8.140

8.  Chromatin-prebound Crm1 recruits Nup98-HoxA9 fusion to induce aberrant expression of Hox cluster genes.

Authors:  Masahiro Oka; Sonoko Mura; Kohji Yamada; Percival Sangel; Saki Hirata; Kazumitsu Maehara; Koichi Kawakami; Taro Tachibana; Yasuyuki Ohkawa; Hiroshi Kimura; Yoshihiro Yoneda
Journal:  Elife       Date:  2016-01-07       Impact factor: 8.140

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.